Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Claxton

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Bone Marrow Transplantation|October 12, 1999
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantationD Przepiorka, I Khouri, C Ippoliti, et al.
Bone Marrow Transplantation|November 1, 1996
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donorsM Körbling, K W Chan, P Anderlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphomaD Przepiorka, K van Besien, I Khouri, et al.
Blood|February 7, 2001
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationS Giralt, P F Thall, I Khouri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcomeU Popat, D Przepiork, R Champlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2000
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1D Przepiorka, R Saliba, K Cleary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancerZ Rahman, J Kavanagh, R Champlin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapyE G Hanania, R E Giles, J Kavanagh, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Bone Marrow Transplantation|October 12, 1999
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantationD Przepiorka, I Khouri, C Ippoliti, et al.
Bone Marrow Transplantation|November 1, 1996
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donorsM Körbling, K W Chan, P Anderlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphomaD Przepiorka, K van Besien, I Khouri, et al.
Blood|February 7, 2001
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationS Giralt, P F Thall, I Khouri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcomeU Popat, D Przepiork, R Champlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2000
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1D Przepiorka, R Saliba, K Cleary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancerZ Rahman, J Kavanagh, R Champlin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapyE G Hanania, R E Giles, J Kavanagh, et al.
Pageof 15